TRCT
YARW

Tower Research Capital (TRC)’s Yarrow Bioscience YARW Stock Holding History

Tower Research Capital (TRC)’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.46K Buy
260
+189
+266% +$6.13K ﹤0.01% 4071
2026
Q1 		$2.11K Hold
71
– – ﹤0.01% 4542
2025
Q4 		$2.07K Sell
71
-1
-1% -$20 ﹤0.01% 4590
2025
Q3 		$1.21K Buy
72
+16
+29% +$523 ﹤0.01% 4846
2025
Q2 		$4.63K Sell
56
-30
-35% -$1.95K ﹤0.01% 4289
2025
Q1 		$6.79K Buy
86
+58
+207% +$7.14K ﹤0.01% 4012
2024
Q4 		$4.64K Sell
28
-16
-36% -$2.09K ﹤0.01% 4427
2024
Q3 		$4.15K Sell
44
-24
-35% -$2.27K ﹤0.01% 4655
2024
Q2 		$6.67K Buy
68
+43
+172% +$5.36K ﹤0.01% 4553
2024
Q1 		$3.81K Buy
25
+9
+56% +$970 ﹤0.01% 4786
2023
Q4 		$1.84K Buy
16
+11
+220% +$1.71K ﹤0.01% 5311
2023
Q3 		$1.09K Buy
+5
New +$1.09K ﹤0.01% 5406
2023
Q2 		– Sell
-2
Closed – – 6388
2023
Q1 		$0 Sell
2
-27
-93% -$4.85K ﹤0.01% 6325
2022
Q4 		$4K Sell
29
-1
-3% -$200 ﹤0.01% 5078
2022
Q3 		$6K Buy
30
+17
+131% +$5.44K ﹤0.01% 5068
2022
Q2 		$5K Buy
13
+5
+63% +$2.1K ﹤0.01% 5111
2022
Q1 		$5K Sell
8
-1
-11% -$594 ﹤0.01% 5119
2021
Q4 		$8K Buy
9
+3
+50% +$3.22K ﹤0.01% 4834
2021
Q3 		$7K Buy
6
+2
+50% +$3.88K ﹤0.01% 4680
2021
Q2 		$14K Sell
4
-1
-20% -$3.96K ﹤0.01% 4194
2021
Q1 		$29K Sell
5
-4
-44% -$29K ﹤0.01% 3590
2020
Q4 		$53K Sell
9
-24
-73% -$151K ﹤0.01% 3078
2020
Q3 		$196K Buy
33
+29
+725% +$169K ﹤0.01% 2597
2020
Q2 		$26K Buy
4
+2
+100% +$13.5K ﹤0.01% 3547
2020
Q1 		$22K Buy
+2
New +$31.4K ﹤0.01% 1675
2019
Q4 		– Sell
-1
Closed -$16.7K – 3334
2019
Q3 		$23K Buy
+1
New +$16.1K ﹤0.01% 2385
2019
Q2 		– Sell
-1
Closed -$24.7K – 2717
2019
Q1 		$21K Sell
1
-2
-67% -$48K ﹤0.01% 2250
2018
Q4 		$44K Buy
+3
New +$67.2K ﹤0.01% 1370
2018
Q3 		– Hold
0
– -$8K – 4292
2018
Q2 		– Hold
0
– – – 2901

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Tower Research Capital (TRC)'s YARW Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Yarrow Bioscience (YARW) stake by 266% in Q2 2026, buying an estimated $6.13K and bringing the position to 260 shares worth $8.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4071.

Tower Research Capital (TRC) first reported a position in YARW in Q4 2018 and has held it in 28 quarters since. The position peaked at $196K in Q3 2020. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Tower Research Capital (TRC) held 260 shares of Yarrow Bioscience worth $8.46K as of Q2 2026.
  • Tower Research Capital (TRC) bought 189 Yarrow Bioscience shares in Q2 2026, an estimated $6.13K.
  • Yarrow Bioscience made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4071 holding.
  • Tower Research Capital (TRC) first reported a position in Yarrow Bioscience in Q4 2018 and has held it in 28 quarters since.
  • Tower Research Capital (TRC)'s Yarrow Bioscience position peaked at $196K in Q3 2020.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.